Wordt geladen...
Sitagliptin and oral cancer risk in type 2 diabetes patients
The reimbursement database of the Taiwan’s National Health Insurance was used to evaluate oral cancer risk after sitagliptin use. Patients newly diagnosed of type 2 diabetes during 1999–2008 were recruited. A 1:1 propensity score matched-pair sample of 39195 ever users and 39195 never users were fol...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722520/ https://ncbi.nlm.nih.gov/pubmed/29228568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18239 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|